Central Sleep Apnea with Cheyne-Stokes Breathing in Heart Failure – From Research to Clinical Practice and Beyond

Abstract

Characterized by periodic crescendo-decrescendo pattern of breathing alternating with central apneas, Central sleep apnea (CSA) with Cheyne-Stokes Breathing represents a highly prevalent, yet underdiagnosed comorbidity in chronic heart failure (CHF). A diverse body of evidence demonstrates increased morbidity and mortality in the presence of CSB. CSB has been described in both CHF patients with preserved and reduced ejection fraction, regardless of drug treatment. Risk factors for CSB are older age, male gender, high BMI, atrial fibrillation and hypocapnia.The pathophysiology of CSB has been explained by the loop gain theory, where a controller (the respiratory center) and a plant (the lungs) are operating in a reciprocal relationship (negative feedback) to regulate a key parameter (partial pressure of carbon dioxide (pCO)). The temporal interaction between these elements is dependent on the circulatory delay. Increased chemosensitivity/chemoresponsiveness of the respiratory center and/or augmented ascending non- CO stimuli from the C-fibers in the lungs (interstitial pulmonary edema), overly efficient ventilation when breathing at low volumes and prolonged circulation time are involved. An alternative hypothesis of CSB being an adaptive response of the failing heart has its merits as well. The clinical manifestation of CSB is usually poor, lacking striking symptoms and complaints. Witnessed apneas and snoring are infrequently reported by the sleep partner. Sometimes patients may report poor sleep quality with frequent awakenings, paroxysmal nocturnal dyspnea and frequent urination at night. Standard instrumental and laboratory studies, performed in CHF patients, may present clues to the presence of CSB. Concentric remodeling of the left ventricle and dilated left atrium (echocardiography), high BNP and C-reactive protein levels, increased ventilation-carbon dioxide output (VEVCO) and lower end-tidal CO (cardiopulmonary exercise testing), reduced diffusion capacity (pulmonary function testing) and hypocapnia (blood-gas analysis) may indicate the presence of CSB.CSB and cardiovascular disease are probably linked through bidirectional causality. Cyclic variations in heart rate, blood pressure, respiratory volume, partial pressure of arterial oxygen (pO) and pCO lead to sympathetic-adrenal activation. The latter worsens ventricular energetism and survival of cardiomyocytes and exerts antiarhythmogenic effects. It causes cardiac remodeling, potentiating the progression and the lethal outcome in CHF patients. Several treatment modalities have been proposed in CSB. The most commonly used are continuous positive airway pressure (CPAP), adaptive servoventilation (ASV) and nocturnal home oxygen therapy (HOT). Novel therapies like nocturnal supplemental CO and phrenic nerve stimulation are being tested recently. The current treatment recommendations (by the American Academy of Sleep Medicine) are for CPAP and HOT as standard therapies, while ASV is an option only in patients with EF > 45%. BPAP (bilevel device) remains an ...

Acetazolamide Therapy in Patients with Heart Failure: A Meta-Analysis

“…In addition, we performed an additional search of the literature to cover recently published articles up to the time of publication. We identified seven other items [34,35,36,37,38,39,40], two of which would qualify for our screening criteria. However, both of the articles did not contain our outcome of interest even though part of the studies involved the usage of acetazolamide.…”

Qualidade de vida e qualidade de sono na insuficiência cardíaca

“…Na ICC foram reconhecidos dois DRS: a apneia obstrutiva do sono (AOS) e apneia central do sono (ACS). A AOS como a ACS interferem no sistema neurohumoral e assim agravam a IC, por exemplo, pelo aumento da atividade nervosa simpática e do eixo renina-angiotensina-aldosterona, ambos alvos das terapias de última geração para IC [8][9][10]18,19 . Vários estudos demonstraram um aumento da mortalidade de pacientes com ICC portadores de DRS, em contraste com aqueles sem DRS 20,18,19 .…”

“…Em adição as consequências da limitação funcional, estudos mostram uma alta prevalência de distúrbios do sono em pacientes com IC. Tais distúrbios foram considerados indicadores da severidade da falência cardíaca nos pacientes com IC da população europeia [7][8][9][10] . As apneias e despertares periódicos fragmentam o sono fortemente, exacerbando a fadiga e causando sonolência diurna excessiva (SDE).…”

Respiración de Cheyne-Stokes en una adolescente con insuficiencia cardíaca secundaria a miocardiopatía dilatada que requirió trasplante cardíaco

“…Esta compleja relación entre la RCS y la ICC, en la que las variaciones cíclicas en la frecuencia cardíaca, presión arterial, volumen respiratorio, presión parcial de O 2 y CO 2 conducen a la hiperactividad simpática, lo que empeora la contracción ventricular y la congestión pulmonar, propone desafíos terapéuticos con el objetivo de atenuar la respiración periódica y, en consecuencia, la actividad simpática. 12 En los adultos, los más utilizados son la administración de oxígeno, la presión positiva continua en la vía aérea y la ventilación servo-adaptativa.…”